Ultragenyx Pharmaceutical INC Form 4 insider transactions

EVP & Chief Commercial Officer of Ultragenyx Pharmaceutical Inc., Erik Harris, reports acquisition and disposal of company stock and stock options.

Ultragenyx Pharmaceutical Inc.'s CEO, Emil Kakkis, reports acquisition and disposal of company stock and stock options.